After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

New Study Shows Promising Results for COPD Treatment Nov. 20 ... Sep. 26, 2024 — What factors lead to chronic respiratory disease? Researchers investigated this question using health data ...

A Midtown-based medical device startup is carving a niche in the growing field of treatments to address chronic lung disease.